Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID	DTD0003 Transporter Info
Gene Name	ABCB1
Transporter Name	P-glycoprotein 1
Gene ID	5243
UniProt ID	P08183

Microbiota Influence of This DT (MBI)

Bacteria: Actinomycetota
Genus: Bifidobacterium
Bifidobacterium adolescentis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Up regulating of ABCB1 expression in colon cancer condition		[2]
Studied Phenotype	Colon cancer [ICD11: 2B90]
Studied Tissue	Colon
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The Bifidobacterium adolescentis has been reported to increase the expression of the drug transporter ABCB1.
Bacteria: Bacillota
Genus: Clostridium
Clostridium sporogenes	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Up regulating of ABCB1 expression in conventional mice compared with germ-free mice		[3] , [4]
Regulating Factor	3-Indolepropionic acid , L-tryptophan
Studied Phenotype	Conventional mice compared with germ-free mice [ICD11: N.A]
Studied Tissue	Small intestine
In Vivo Model	Swiss Webster germ-free mice
In Vitro Model	Human kidney human embryonic kidney 293T cells (HEK 293T)
Detailed Description	The metabolite 3-indolepropionic acid and l-tryptophan generated from the metabolism of indole by the Clostridium sporogenes has been reported to increase the expression of the drug transporter ABCB1.
Unclassified Clostridium	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Down regulating of ABCB1 expression in type 1 diabetes mellitus condition		[1]
Studied Phenotype	Type 1 diabetes mellitus [ICD11: 5A10]
Studied Tissue	Colon
In Vivo Model	Diabetic sprague-dawley rats
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The Unclassified Clostridium stricto 1 has been reported to decrease the expression of the drug transporter ABCB1.
Genus: Eubacterium
Unclassified Eubacterium	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Up regulating of ABCB1 expression in the health condition		[5]
Regulation Mechanism	may via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) and Nuclear receptor subfamily 1 group I member 2 (NR1I2)
Studied Tissue	Colon
In Vivo Model	C57BL/6J mice
In Vitro Model	Human lung mucoepidermoid carcinoma cells (NCI-H292)
Detailed Description	The Unclassified Eubacterium has been reported to increase the expression of the drug transporter ABCB1.
Genus: Lachnoclostridium
Unclassified Lachnoclostridium	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Down regulating of ABCB1 expression in type 1 diabetes mellitus condition		[1]
Studied Phenotype	Type 1 diabetes mellitus [ICD11: 5A10]
Studied Tissue	Colon
In Vivo Model	Diabetic sprague-dawley rats
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The Unclassified Lachnoclostridium has been reported to decrease the expression of the drug transporter ABCB1.
Genus: Lactobacillus
Unclassified Lactobacillus	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Up regulating of ABCB1 expression in the health condition		[5]
Regulation Mechanism	may via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) and Nuclear receptor subfamily 1 group I member 2 (NR1I2)
Studied Tissue	Colon
In Vivo Model	C57BL/6J mice
In Vitro Model	Human lung mucoepidermoid carcinoma cells (NCI-H292)
Detailed Description	The Unclassified Lactobacillus has been reported to increase the expression of the drug transporter ABCB1.
Genus: Ligilactobacillus
Ligilactobacillus murinus	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Down regulating of ABCB1 expression in colon adenocarcinoma condition		[6]
Studied Phenotype	Colon cancer [ICD11: 2B90]
Studied Tissue	Colon
In Vivo Model	Sprague-Dawley specific pathogen free rats
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The Ligilactobacillus murinus has been reported to decrease the expression of the drug transporter ABCB1.
Genus: Romboutsia
Unclassified Romboutsia	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Down regulating of ABCB1 expression in type 1 diabetes mellitus condition		[1]
Studied Phenotype	Type 1 diabetes mellitus [ICD11: 5A10]
Studied Tissue	Colon
In Vivo Model	Diabetic sprague-dawley rats
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The Unclassified Romboutsia has been reported to decrease the expression of the drug transporter ABCB1.
Genus: Turicibacter
Unclassified Turicibacter	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Down regulating of ABCB1 expression in type 1 diabetes mellitus condition		[1]
Studied Phenotype	Type 1 diabetes mellitus [ICD11: 5A10]
Studied Tissue	Colon
In Vivo Model	Diabetic sprague-dawley rats
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The Unclassified Turicibacter has been reported to decrease the expression of the drug transporter ABCB1.
Bacteria: Bacteroidota
Genus: Bacteroides
Bacteroides thetaiotaomicron	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Down regulating of ABCB1 expression in conventional mice compared with germ-free mice		[7]
Studied Phenotype	Conventional mice compared with germ-free mice [ICD11: N.A]
Studied Tissue	Intestine
In Vivo Model	Germ-free mice
Detailed Description	The Bacteroides thetaiotaomicron has been reported to decrease the expression of the drug transporter ABCB1.
Genus: Unclassified Prevotellaceae
Prevotellaceae NK3B31	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Down regulating of ABCB1 expression in type 1 diabetes mellitus condition		[1]
Studied Phenotype	Type 1 diabetes mellitus [ICD11: 5A10]
Studied Tissue	Colon
In Vivo Model	Diabetic sprague-dawley rats
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The Unclassified Prevotellaceae has been reported to decrease the expression of the drug transporter ABCB1.
Microbe Influence 2	Down regulating of ABCB1 expression in type 1 diabetes mellitus condition		[1]
Studied Phenotype	Type 1 diabetes mellitus [ICD11: 5A10]
Studied Tissue	Colon
In Vivo Model	Diabetic sprague-dawley rats
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The Unclassified Prevotellaceae has been reported to decrease the expression of the drug transporter ABCB1.
Bacteria: Pseudomonadota
Genus: Escherichia
Escherichia coli	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human ABCB1 substrates/drugs in the health condition		[8]
Regulating Factor	ompF
Detailed Description	The protein ompF of Escherichia coli JM712 has been reported to transport similar substrates/drugs of ABCB1, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 2	Sequestration of human ABCB1 substrates/drugs in the health condition		[9]
Detailed Description	The Escherichia coli str. K-12 substr. MG1655 has been reported to sequester the drug Chloramphenicol and Tetracycline, which limits the distribution of the drug in the body and its binding to the drug transporter ABCB1, thereby affecting the efficacy, safety, or bioavailability of the drug.
Microbe Influence 3	Up regulating of ABCB1 expression in colon cancer condition		[2]
Studied Phenotype	Colon cancer [ICD11: 2B90]
Studied Tissue	Colon
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The Escherichia coli Nissle 1917 has been reported to increase the expression of the drug transporter ABCB1.
Genus: Salmonella
Salmonella enterica	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human ABCB1 substrates/drugs in the health condition		[10]
Regulating Factor	ompF
Detailed Description	The protein ompF of Salmonella enterica subsp. enterica serovar Typhi 1895 has been reported to transport similar substrates/drugs of ABCB1, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 2	Down regulating of ABCB1 expression in colon adenocarcinoma condition		[11] , [12]
Studied Phenotype	Colon cancer [ICD11: 2B90]
Studied Tissue	Colon
In Vitro Model	Madin-Darby canine kidney cells (MDCKII)
Detailed Description	The Salmonella enterica subsp. enterica serovar Typhimurium has been reported to decrease the expression of the drug transporter ABCB1.
Bacteria: Host unspecified microbiota
Genus: Unknown microbiota
Host unspecified microbiota		Click to Show/Hide the Full List 23 Microbe Influence Related to This Species
Microbe Influence 1	Up regulating of ABCB1 expression in conventional mice compared with germ-free mice		[3]
Regulating Factor	3-Indolepropionic acid
Regulation Mechanism	via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2)		Transcription Factor Info
Studied Phenotype	Conventional mice compared with germ-free mice [ICD11: N.A]
Studied Tissue	Small intestine
In Vivo Model	C57BL/6J germ-free mice
Detailed Description	The metabolite 3-indolepropionic acid generated from the metabolism of l-tryptophan by the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 2	Up regulating of ABCB1 expression in the health condition		[3]
Regulating Factor	3-Indolepropionic acid
Regulation Mechanism	via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2)		Transcription Factor Info
Studied Tissue	Ileum
In Vivo Model	C57BL/6J conventionally-raised mice
Detailed Description	The metabolite 3-indolepropionic acid generated from the metabolism of l-tryptophan by the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 3	Up regulating of ABCB1 expression in the health condition		[3]
Regulating Factor	3-Indolepropionic acid
Regulation Mechanism	via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2)		Transcription Factor Info
Studied Tissue	Jejunum
In Vivo Model	C57BL/6J conventionally-raised mice
Detailed Description	The metabolite 3-indolepropionic acid generated from the metabolism of l-tryptophan by the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 4	Up regulating of ABCB1 expression in the health condition		[3]
Regulating Factor	L-Tryptophan
Regulation Mechanism	via enhancement of Nuclear receptor subfamily 1 group I member 2 (NR1I2)		Transcription Factor Info
Studied Tissue	Duodenum
In Vivo Model	C57BL/6J conventionally-raised mice
Detailed Description	The metabolite l-tryptophan generated from the metabolism of dietary food by the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 5	Up regulating of ABCB1 expression in the health condition		[5]
Regulating Factor	Butyrate
Regulation Mechanism	via inhibition of histone deacetylases (HDAC) to alter transcription
Studied Tissue	Colon
In Vivo Model	C57BL/6J mice
In Vitro Model	Human lung mucoepidermoid carcinoma cells (NCI-H292)
Detailed Description	The metabolite butyrate generated from the metabolism of dietary food by the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 6	Down regulating of ABCB1 expression in the health condition		[13]
Regulating Factor	Urolithin A
Studied Tissue	Colon
In Vivo Model	NRGS mice
In Vitro Model	Human colon carcinoma cells (HCT-116)
Detailed Description	The metabolite urolithin a generated from the metabolism of dietary polyphenols by the host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCB1.
Microbe Influence 7	Inhibition of ABCB1 function in the health condition		[14]
Regulating Factor	Glycochenodeoxycholic acid
Studied Tissue	Intestine
Detailed Description	The metabolite glycochenodeoxycholic acid generated from the host unspecified microbiota has been reported to inhibit the function of the drug transporter ABCB1.
Microbe Influence 8	Inhibition of ABCB1 function in colon cancer condition		[14] , [15]
Regulating Factor	Sodium taurocholate
Studied Phenotype	Colon cancer [ICD11: 2B90]
Studied Tissue	Colon
In Vitro Model	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	The metabolite sodium taurocholate generated from the host unspecified microbiota has been reported to inhibit the function of the drug transporter ABCB1.
Microbe Influence 9	Up regulating of ABCB1 expression in colon cancer condition		[16]
Regulating Factor	Chenodeoxycholic acid
Studied Phenotype	Colon cancer [ICD11: 2B90]
Studied Tissue	Colon
In Vitro Model	Human colon adenocarcinoma cells (HT-29)
Detailed Description	The metabolite chenodeoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 10	Up regulating of ABCB1 expression in colon cancer condition		[16]
Regulating Factor	Deoxycholic acid
Studied Phenotype	Colon cancer [ICD11: 2B90]
Studied Tissue	Colon
In Vitro Model	Human colon adenocarcinoma cells (HT-29)
Detailed Description	The metabolite deoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 11	Activation of ABCB1 function in health condition		[5]
Regulating Factor	Deoxycholic acid
Regulation Mechanism	may via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) and Nuclear receptor subfamily 1 group I member 2 (NR1I2)
Studied Tissue	Lung
In Vivo Model	C57BL/6J mice
In Vitro Model	Human lung mucoepidermoid carcinoma cells (NCI-H292)
Detailed Description	The metabolite deoxycholic acid generated from the host unspecified microbiota has been reported to activate the function of the drug transporter ABCB1.
Microbe Influence 12	Activation of ABCB1 function in health condition		[5]
Regulating Factor	Lithocholic acid
Regulation Mechanism	may via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) and Nuclear receptor subfamily 1 group I member 2 (NR1I2)
Studied Tissue	Lung
In Vivo Model	C57BL/6J mice
In Vitro Model	Human lung mucoepidermoid carcinoma cells (NCI-H292)
Detailed Description	The metabolite lithocholic acid generated from the host unspecified microbiota has been reported to activate the function of the drug transporter ABCB1.
Microbe Influence 13	Up regulating of ABCB1 expression in the health condition		[5]
Regulating Factor	Lithocholic acid
Regulation Mechanism	may via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) and Nuclear receptor subfamily 1 group I member 2 (NR1I2)
Studied Tissue	Colon
In Vivo Model	C57BL/6J mice
In Vitro Model	Human lung mucoepidermoid carcinoma cells (NCI-H292)
Detailed Description	The metabolite lithocholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 14	Activation of ABCB1 function in health condition		[5]
Regulating Factor	Ursodeoxycholic acid
Regulation Mechanism	may via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) and Nuclear receptor subfamily 1 group I member 2 (NR1I2)
Studied Tissue	Lung
In Vivo Model	C57BL/6J mice
In Vitro Model	Human lung mucoepidermoid carcinoma cells (NCI-H292)
Detailed Description	The metabolite ursodeoxycholic acid generated from the host unspecified microbiota has been reported to activate the function of the drug transporter ABCB1.
Microbe Influence 15	Up regulating of ABCB1 expression in the health condition		[5]
Regulating Factor	Ursodeoxycholic acid
Regulation Mechanism	may via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) and Nuclear receptor subfamily 1 group I member 2 (NR1I2)
Studied Tissue	Colon
In Vivo Model	C57BL/6J mice
In Vitro Model	Human lung mucoepidermoid carcinoma cells (NCI-H292)
Detailed Description	The metabolite ursodeoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 16	Inhibition of ABCB1 function in the health condition		[14]
Regulating Factor	Taurochenodeoxycholic acid
Studied Tissue	Intestine
Detailed Description	The metabolite taurochenodeoxycholic acid generated from the host unspecified microbiota has been reported to inhibit the function of the drug transporter ABCB1.
Microbe Influence 17	Inhibition of ABCB1 function in the health condition		[14]
Regulating Factor	Taurolithocholic acid
Studied Tissue	Intestine
Detailed Description	The metabolite taurolithocholic acid generated from the host unspecified microbiota has been reported to inhibit the function of the drug transporter ABCB1.
Microbe Influence 18	Up regulating of ABCB1 expression in the health condition		[17]
Regulating Factor	Chenodeoxycholic acid
Studied Tissue	Ileum
In Vivo Model	C57BL/6J mice
In Vitro Model	Mouse precursor T cell lymphoblastic lymphoma cells(EL4)
Detailed Description	The metabolite chenodeoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 19	Up regulating of ABCB1 expression in the health condition		[17]
Regulating Factor	Cholic acid
Studied Tissue	Ileum
In Vivo Model	C57BL/6J mice
In Vitro Model	Mouse precursor T cell lymphoblastic lymphoma cells(EL4)
Detailed Description	The metabolite cholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 20	Up regulating of ABCB1 expression in the health condition		[17]
Regulating Factor	Deoxycholic acid
Studied Tissue	Ileum
In Vivo Model	C57BL/6J mice
In Vitro Model	Mouse precursor T cell lymphoblastic lymphoma cells(EL4)
Detailed Description	The metabolite deoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.
Microbe Influence 21	Inhibition of ABCB1 function in the health condition		[14] , [18]
Regulating Factor	Sodium 12-Oxochenodeoxycholate
Studied Tissue	Brain
In Vitro Model	Rat brain microvascular endothelial cells (RBE4)
Detailed Description	The compound sodium 12-oxochenodeoxycholate generated by host unspecified microbiota has been reported to inhibit the function of the drug transporter ABCB1.
Microbe Influence 22	Down regulating of ABCB1 expression in conventional mice compared with germ-free mice		[19] , [20]
Studied Phenotype	Conventional mice compared with germ-free mice [ICD11: N.A]
Studied Tissue	Small intestine
In Vivo Model	C57BL/6N mice
Detailed Description	The host unspecified microbiota has been reported to decrease the expression of the drug transporter ABCB1.
Microbe Influence 23	Up regulating of ABCB1 expression in hypoxia condition		[21]
Studied Phenotype	Hypoxia [ICD11: MD11.1]
Studied Tissue	Liver
In Vivo Model	Sprague-Dawley rats
Detailed Description	The host unspecified microbiota has been reported to increase the expression of the drug transporter ABCB1.

References
1	The gut microbiota contributes to the modulation of intestinal CYP3A1 and P-gp in streptozotocin-induced type 1 diabetic rats. Eur J Pharm Sci. 2021 Jul 1;162:105833.
2	Causative Role of Anoxic Environment in Bacterial Regulation of Human Intestinal Function. Cell Mol Bioeng. 2022 Sep 16;15(5):493-504.
3	Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting. Drug Metab Dispos. 2018 May;46(5):503-513.
4	Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity. 2014 Aug 21;41(2):296-310.
5	Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis. Microbiome. 2021 Sep 7;9(1):183.
6	Lactobacillus murinus Improved the Bioavailability of Orally Administered Glycyrrhizic Acid in Rats. Front Microbiol. 2020 Apr 24;11:597.
7	Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001 Feb 2;291(5505):881-4.
8	The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. J Antimicrob Chemother. 1993 Aug;32(2):195-213.
9	Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature. 2017 May 18;545(7654):299-304.
10	Clinical isolate of a porinless Salmonella typhi resistant to high levels of chloramphenicol. Antimicrob Agents Chemother. 1990 Sep;34(9):1715-9.
11	The interaction of gut microbes with host ABC transporters. Gut Microbes. 2010 Sep;1(5):301-306.
12	Salmonella enterica serovar Typhimurium modulates P-glycoprotein in the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol. 2008 Jun;294(6):G1392-400.
13	Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis. Theranostics. 2022 Jul 18;12(12):5574-5595.
14	The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B. 2021 Jul;11(7):1789-1812.
15	Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers. Int J Pharm. 2004 Apr 15;274(1-2):221-32.
16	Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein. Mol Pharm. 2018 Dec 3;15(12):5711-5727.
17	The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids. Immunity. 2017 Dec 19;47(6):1182-1196.e10.
18	Mechanistic studies of the effect of bile salts on rhodamine 123 uptake into RBE4 cells. Mol Pharm. 2012 Jan 1;9(1):29-36.
19	New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium. Clin Pharmacol Ther. 2022 Sep;112(3):540-561.
20	Proteomic analysis of small intestinal epithelial cells in antibiotic-treated mice: Changes in drug transporters and metabolizing enzymes. Drug Metab Pharmacokinet. 2019 Apr;34(2):159-162.
21	Regulation of CYP450 and drug transporter mediated by gut microbiota under high-altitude hypoxia. Front Pharmacol. 2022 Sep 15;13:977370.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Microbiota Influence

Visitor Map

Correspondence